Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar;21(1):173-6.
doi: 10.1007/BF02913090.

Significance of tumor markers in lung cancer

P P Mumbarkar  1 , A S Raste, M S Ghadge
Affiliations

Significance of tumor markers in lung cancer

P P Mumbarkar et al. Indian J Clin Biochem. 2006 Mar.

Abstract

The objective was to test the utility of the cytokeratins CYFRA 21-1, tissue polypeptide specific antigen (TPS), Neuron specific enolase (NSE) and Carcino Embryonic antigen (CEA) in patients with lung cancer and in the pleural fluid of the patients with lung cancer and also the predicting ability of these tumor markers with respect to the histological types [including non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)] and pathological stages. 40 normal subjects and 222 cases of histological proven lung cancer were studied. The findings suggest that TPS and CYFRA 21-1, are useful serum markers for the diagnosis of NSCLC and NSE seems to be useful tumor marker for monitoring course of patients especially SCLC. The combined use of these cytokeratin markers TPS and CYFRA 21-1 may provide additional information for prognosis.

PubMed Disclaimer

References

    1. Pamies R.J., Crawford D.R. Tumor markers: an update. Med. Clin. North Am. 1996;80:185–199. doi: 10.1016/S0025-7125(05)70435-1. - DOI - PubMed
    1. Coombes R.C., Powels T.J. Tumor markers in the management of human cancer. In: Deeley T.J., editor. Topical reviews in radiotherapy and oncology. Bristol, UK: Wright PGS; 1982. pp. 39–39.
    1. Buccheri G., Ferrigno D. Lung tumor markers of cytokeratin origin: an overview. Lung Cancer. 2001;34:S65–S69. doi: 10.1016/S0169-5002(01)00347-6. - DOI - PubMed
    1. Bjorklund B. Tissue polypeptide antigen (TPA): biology, biochemistry, improved assay methodology, clinical significance in cancer and other conditions, and future outlook. In: Schonfeld H., editor. Laboratory testing for cancer. Basel. Switzerland: Karger; 1978. pp. 16–31. - PubMed
    1. Broers J.L., Ramaekers F.C., Rot M.K., et al. Cytokeratins in different types of lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res. 1988;48:3221–3229. - PubMed

LinkOut - more resources